Reena Philip

4.9k citations
45 papers · 3.9k · 2 hit papers · h-index 31

Impact in

  • Oncology top 2%
    • PARP inhibition in cancer therapy
    • Cancer Immunotherapy and Biomarkers
    • Cancer Genomics and Diagnostics
    • Breast Cancer Treatment Studies

Papers in

    • Cancer Genomics and Diagnostics 13
    • PARP inhibition in cancer therapy 7
    • Cancer Immunotherapy and Biomarkers 5

Reena Philip

45 papers receiving 3.8k citations

Reena Philip's Hit Papers

FDA Approval Summary: Pembrolizumab for the Treatment of Tumor Mutational Burden–High Solid Tumors 2021 · 442 citations
4420+5+10Years since publication200400600

Peers

Reena Philip
Comparison fields: 5 of 119
  • Oncology 1.1k
  • Cancer Research 651
  • Pulmonary and Respiratory Medicine 598
  • Molecular Biology 749
  • Reproductive Medicine 114
Replace Carolyn D. Britten with:
Carolyn D. Britten United States
Pierre Saintigny France
Emily W. Chan United States
Emma Jane Dean United Kingdom
Eddy Shih-Hsin Yang United States
José Alejandro Pérez Fidalgo Spain
Christine A. Pratilas United States
Mónica Arnedos France
Antoinette R. Tan United States
Daniel Richard Wahl United States
Reena Philip relative to Carolyn D. Britten United States Carolyn D. Britten's profile →
Citations per field
00.5×2×2.5×
Carolyn D. Britten · 1×
Citations per year

Countries citing papers authored by Reena Philip

Since Specialization
Citations

This map shows the geographic impact of Reena Philip's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Reena Philip with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Reena Philip more than expected).

Fields of papers citing papers by Reena Philip

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Reena Philip. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Reena Philip. The network helps show where Reena Philip may publish in the future.

Co-authors

The 25 scholars most cited alongside Reena Philip, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Reena Philip Line = papers co-authored together Reena Philip links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 45 papers — load more, or switch the sort, to bring in the rest.

#Work
1
The MicroArray Quality Control (MAQC)-II study of common practices for the development and validation of microarray-based predictive models
Hit paper breakdown →
2010711
2 2015458
3
FDA Approval Summary: Pembrolizumab for the Treatment of Tumor Mutational Burden–High Solid Tumors
Hit paper breakdown →
2021442
4 2018191
5 2020149
6 2017145
7 2020145
8 2020134
9 2020131
10 2021115
11 2018113
12 2018103
13 200496
14 202185
15 202264
16 202060
17 202156
18 201754
19 202354
20 200152

About Reena Philip

Reena Philip is a scholar working on Cancer Research, Oncology, Pulmonary and Respiratory Medicine, Health Information Management and Physiology, having authored 45 papers that have together received 3.9k indexed citations. Recurring topics across this work include Cancer Genomics and Diagnostics (13 papers), Lung Cancer Treatments and Mutations (7 papers), PARP inhibition in cancer therapy (7 papers), Cancer Immunotherapy and Biomarkers (5 papers), Healthcare Regulation (4 papers), Clinical Laboratory Practices and Quality Control (3 papers), Biomedical Ethics and Regulation (3 papers) and Gene expression and cancer classification (3 papers). The work is most often cited by research in Oncology (1.1k citations), Cancer Research (651 citations), Pulmonary and Respiratory Medicine (598 citations), Molecular Biology (749 citations) and Reproductive Medicine (114 citations). Reena Philip has collaborated with scholars based in United States, Spain and Canada. Frequent co-authors include Richard Pazdur, Julia A. Beaver, Soma Ghosh, Lisa Rodríguez, Martha Boeri Donoghue, Steven J. Lemery, Lola A. Fashoyin‐Aje, Leigh Jessica Marcus, Mengdie Yuan and Marc Robert Theoret. Their work appears in journals such as Clinical Cancer Research, The Oncologist, Clinical Chemistry, JCO Precision Oncology and BMC Genomics.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact